Ceflact Pharmaceuticals Private Limited
About Ceflact Pharmaceuticals Private Limited
Data last updated:
Ceflact Pharmaceuticals Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 22 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2015PTC070273. Its GSTIN is 09AAGCC0483L1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Niti Mishra and Ashutosh Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 327 Lig Govindpur Housing Scheme, Allahabad, Uttar Pradesh, India – 211004.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.82 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net loss of ₹15,077 (net margin -2.6%) and EBITDA of ₹29,502 (EBITDA margin 5.1%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address327 Lig Govindpur Housing Scheme, Allahabad, Uttar Pradesh, India – 211004
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ceflact Pharmaceuticals Private Limited
The main business activity of Ceflact Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ceflact Pharmaceuticals Private Limited FY 2025 filings available
Ceflact Pharmaceuticals Private Limited reported revenue of ₹5.82 Lakh (up 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Ceflact Pharmaceuticals Private Limited
Revenue rose 19% in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ceflact Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹29,502 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹15,077 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ceflact Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -2.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ceflact Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ceflact Pharmaceuticals Private Limited
Ceflact Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Niti Mishra | Director | 21 Nov 2016 | 9 Years 10 Months | Current |
| Ashutosh Mishra | Director | 22 Apr 2015 | 11 Years 5 Months | Current |
Peer Comparison of Ceflact Pharmaceuticals Private Limited
Ceflact Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gyrus Pharmaceuticals Private Limited | ₹5.85 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Amritsar, Punjab, India |
| Geetanjali Pharmaceuticals (India) P. Ltd. | ₹5.85 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Thane, Maharashtra, India |
| Maclaren Pharmaceuticals Private Limited | ₹5.84 Lakh (FY 2022) | •••• | •••• | -16.0% | •••• | Bareilly, Uttar Pradesh, India |
| Avatis Pharmaceuticals (OPC) Private Limited | ₹5.83 Lakh (FY 2025) | •••• | •••• | 43.0% | •••• | Mumbai, Maharashtra, India |
| Symbselect Pharmaceuticals (OPC) Private Limited | ₹5.82 Lakh (FY 2025) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Ceflact Pharmaceuticals Private Limited this company | ₹5.82 Lakh (FY 2024) | •••• | •••• | 19.0% | •••• | Allahabad, Uttar Pradesh, India |
| Carolus Pharmaceuticals Private Limited | ₹5.82 Lakh (FY 2024) | •••• | •••• | -63.0% | •••• | New Delhi, Delhi, India |
| Sree Rakhadi Bio Pharmaceuticals Private Limited | ₹5.77 Lakh (FY 2019) | •••• | •••• | -23.0% | •••• | Hyderabad, Telangana, India |
| Rivisa Pharmaceuticals (OPC) Private Limited | ₹5.76 Lakh (FY 2025) | •••• | •••• | 23.0% | •••• | Hosur, Tamil Nadu, India |
| Xida Pharmaceuticals Private Limited | ₹5.74 Lakh (FY 2021) | •••• | •••• | -74.0% | •••• | Behrampore, West Bengal, India |
| Elowen Pharmaceuticals Private Limited | ₹5.69 Lakh (FY 2024) | •••• | •••• | 28463650.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Ceflact Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ceflact Pharmaceuticals Private Limited
Ceflact Pharmaceuticals Private Limited is audited by ANUJ KHANDELWAL & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANUJ KHANDELWAL & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Ceflact Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ceflact Pharmaceuticals Private Limited
Ceflact Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ceflact Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Ceflact Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ceflact Pharmaceuticals Private Limited
Ceflact Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Arvind Kumar Shukla ceased to be Director on 29 Sep 2017.
Credit Ratings, Litigation & Regulatory Alerts for Ceflact Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ceflact Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ceflact Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ceflact Pharmaceuticals Private Limited
Ceflact Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCC0483L1ZE | Uttar Pradesh | Active | 26 Aug 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ceflact Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceflact Pharmaceuticals Private Limited
Ceflact Pharmaceuticals is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in wholesale, within the trading industry. It was incorporated on 22 April 2015 (11+ years old) and is registered under CIN U24233UP2015PTC070273.
Ceflact Pharmaceuticals reported revenue of ₹5.82 Lakh for FY 2024 (up 19% YoY).
Ceflact Pharmaceuticals has 2 current directors:
- Niti Mishra - Director
- Ashutosh Mishra - Director
Ceflact Pharmaceuticals reported a net loss of ₹15,077 (net margin -2.6%) and EBITDA of ₹29,502 (EBITDA margin 5.1%) for FY 2024, as per its filed financial statements.
The GSTIN of Ceflact Pharmaceuticals is 09AAGCC0483L1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ceflact Pharmaceuticals is U24233UP2015PTC070273. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ceflact Pharmaceuticals was incorporated on 22 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Ceflact Pharmaceuticals by revenue are Gyrus Pharmaceuticals Private Limited, Geetanjali Pharmaceuticals (India) P. Ltd, Maclaren Pharmaceuticals Private Limited, Avatis Pharmaceuticals (OPC) Private Limited, Symbselect Pharmaceuticals (OPC) Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Arvind Kumar Shukla ceased to be Director on 29 Sep 2017. Ram Sajiwan Mishra ceased to be Director on 29 Sep 2017. Rohan Srivastava ceased to be Director on 24 Nov 2016. Ceflact Pharmaceuticals has 5 board changes on record in total.
The registered office of Ceflact Pharmaceuticals is at 327 Lig Govindpur Housing Scheme, Allahabad, Uttar Pradesh, India – 211004.
Ceflact Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.